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Abstract
Background: Pancreatic cancer is the 5th leading cause of cancer death in both males and females. In recent
years, a wealth of gene and protein expression studies have been published broadening our understanding of
pancreatic cancer biology. Due to the explosive growth in publicly available data from multiple different sources
it is becoming increasingly difficult for individual researchers to integrate these into their current research
programmes. The Pancreatic Expression database, a generic web-based system, is aiming to close this gap by
providing the research community with an open access tool, not only to mine currently available pancreatic
cancer data sets but also to include their own data in the database.
Description:  Currently, the database holds 32 datasets comprising 7636 gene expression measurements
extracted from 20 different published gene or protein expression studies from various pancreatic cancer types,
pancreatic precursor lesions (PanINs) and chronic pancreatitis. The pancreatic data are stored in a data
management system based on the BioMart technology alongside the human genome gene and protein annotations,
sequence, homologue, SNP and antibody data. Interrogation of the database can be achieved through both a web-
based query interface and through web services using combined criteria from pancreatic (disease stages,
regulation, differential expression, expression, platform technology, publication) and/or public data (antibodies,
genomic region, gene-related accessions, ontology, expression patterns, multi-species comparisons, protein data,
SNPs). Thus, our database enables connections between otherwise disparate data sources and allows relatively
simple navigation between all data types and annotations.
Conclusion: The database structure and content provides a powerful and high-speed data-mining tool for cancer
research. It can be used for target discovery i.e. of biomarkers from body fluids, identification and analysis of genes
associated with the progression of cancer, cross-platform meta-analysis, SNP selection for pancreatic cancer
association studies, cancer gene promoter analysis as well as mining cancer ontology information. The data model
is generic and can be easily extended and applied to other types of cancer. The database is available online with
no restrictions for the scientific community at http://www.pancreasexpression.org/.
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Background
Pancreatic ductal adenocarcinoma (PDAC) usually
presents at an advanced stage so that surgical cure is rarely
achieved and conventional chemotherapy and radiother-
apy have little impact, resulting in a very low 5-year sur-
vival rate (0.5%–5%) [1]. Thus a number of laboratories
have focused on studying the evolution of pancreatic can-
cer from its earliest stages (pancreatic intraepithelial neo-
plasias or PanINs), putting pancreatic cancer among the
best studied tumour tissue types at the molecular level.
Thus a wealth of information regarding mutated and aber-
rantly expressed genes, miRNAs and proteins is now avail-
able, not only significantly boosting our biological
understanding of the disease but also helping to identify
new (early) diagnostic and therapeutic targets. Unfortu-
nately, the huge and still rising volume and diversity of
public pancreatic datasets makes it increasingly difficult
for researchers to integrate this information into their cur-
rent research efforts. In this report, we describe a dedi-
cated Pancreatic Expression database [2] aiming to
overcome this restriction, and furthermore propose it as a
generic model for the organization, integration and pres-
entation of complex cancer research data. The model is
designed to address various research problems, ranging
from the specimen origin and type, through cancer devel-
opment stages to expression patterns. By bringing com-
plex profiling data together, the Pancreatic Expression
database should enable scientists worldwide to perform a
whole range of user-friendly queries, from deciphering the
biological mechanisms underlying pancreatic disease to
target discovery.
Construction and Content
Construction
The aim of the Pancreatic Expression database is to pro-
vide a comprehensive mining tool for large-scale
genomic, transcriptomic and proteomic data sets. In order
to achieve this, we designed a robust internal structure
encompassing specific pre-defined modules (which can
be found under the "Filters" section in the database)
including "pancreatic specimen/cell type", "pancreatic differ-
ential expression information", "genes differentially expressed
in" and "genes expressed in" modules. Our design enables
uploading of any available (pancreatic) datasets that com-
ply with the structure of the pre-defined modules. Each
module contains a number of subcategories related to the
module name, which are fundamental to store and
retrieve user-defined sub-datasets from the database by
setting filters to the specific subcategories within each
module. The "pancreatic specimen/cell type" module covers
categories such as normal (microdissected ductal cells
(ND) or bulk normal pancreas (NP), acinar cells, islet
cells, stromal cells and pancreatic stellate cells), and dis-
ease specimens from both exocrine (pancreatic intraepi-
thelial neoplasias (PanIN-1A, PanIN-1B, PanIN-2, PanIN-
3), chronic pancreatitis (CP), pancreatic adenocarcinoma
(PDAC), intraductal papillary mucinous neoplasms
(IPMN), mucinous cystic tumours and ampullary carci-
noma) and endocrine (functioning and non-functioning
tumours) origin. Moreover, pancreatic juice, plasma,
urine, serum, and fine needle aspirates are included as
additional options to further broaden future expansion of
the database. The "pancreatic differential expression informa-
tion" module provides information on direction of regula-
tion (up- and down-regulation), fold-change, SAGE tag
number and whether a gene or protein was found to be
expressed only in pancreatic adenocarcinoma (PDAC) or
in normal pancreas. The "genes differentially expressed in"
module enables more defined selection of comparison
methods such as pancreatic adenocarcinoma (PDAC) ver-
sus normal pancreas (bulk tissue or microdissected nor-
mal ductal cells), chronic pancreatitis (CP) versus normal
pancreas (bulk tissue or microdissected normal ductal
cells), chronic pancreatitis (CP) versus pancreatic adeno-
carcinoma (PDAC), pancreatic intraepithelial neoplasias
(PanIN-1A, PanIN-1B, PanIN-2 or PanIN-3) versus nor-
mal pancreas (ND) or microdissected normal ductal
cells), etc. The "genes expressed in" module lists the genes
expressed in the tissue types defined in the pancreatic
specimen/cell module, irrespective of their mode of regu-
lation (whether they are differentially expressed or not).
The "platform technology" module enables the selection of
the technology used, such as Affymetrix arrays, cDNA
arrays, Sanger human 10K cDNA arrays version 1.2.1,
Sanger custom 5K1 cDNA arrays, Clontech Atlas Human
Cancer cDNA Expression Array, SAGE, Agilent Human
Genome CGH array, 2D PAGE, SELDI, etc. The data is
stored in a data management system created using MySQL
[3] and based on the open-source BioMart technology [4],
a simple, federated query system designed specifically for
use with large datasets. We imported the available
Ensembl [5] human genome annotations (Ensembl
release 41) for genes and proteins, SNP information,
sequences, gene structure and multi-species data enabling
the integration and annotation of heterogeneous pancre-
atic cancer data. In order to avoid integration and annota-
tions errors, we used the pre-established Ensembl
annotations and microarray probe set mapping. Ensembl
links to UniProt/Swiss-Prot, RefSeq and UniProt/TrEMBL
databases are made on the basis of sequence similarity. All
other subsequent links are inferred from these mappings.
Ensembl also establishes mappings to microarray probe
set identifiers by matching probe set sequences to
Ensembl transcripts [6]. We also integrated the antibody
data from the Human Protein Atlas [7] based on Ensembl
gene ID.
Content
The Pancreatic Expression database currently contains 32
datasets from 20 different published sources, from 14BMC Genomics 2007, 8:439 http://www.biomedcentral.com/1471-2164/8/439
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international laboratories encompassing 22 different plat-
forms (Affymetrix GeneChip Human Full Length Array
HuGeneFL, Affymetrix GeneChip Human Genome U95
Set (HG-U95A, HG-U95B, HG-U95C, HG-U95D, HG-
U95E), Affymetrix GeneChip Human Genome U133
Array Set (HG-U133A, HG-U133B), 2D PAGE, cDNA
arrays, SAGE, Operon oligo array version 2.0, Clontech
Atlas Human Cancer cDNA Expression Array, immuno-
histochemistry, in situ hybridisation, Oligo array, MALDI,
mass spectrometry, Sanger human 10K cDNA arrays ver-
sion 1.2.1, Sanger custom 5K1 cDNA arrays, United Gene
Technique Ltd, BD PowerBlot Western array and qRT-
PCR) [8-27]. These initial datasets provide valuable infor-
mation about 7636 gene expression measurements from
a first-pass selection of relevant papers in the field of pan-
creatic research; however, the inclusion of additional rele-
vant datasets will be a continuous and ongoing process.
All the datasets were manually processed, checked for
accuracy and consistency and loaded into our relational
database alongside annotations from several public
resources such as Ensembl, GO, dbSNP, UniProt and the
Human protein atlas. Currently, several modules are
present for which data are either not yet incorporated or
not available (ICAT, iTRAQ), but these will be populated
as it is our intention to continuously extend the current
data content and cover all the existing modules as and
when the data becomes available.
Utility and Discussion
Data access
The Pancreatic Expression database provides access not
only to bioinformatic and biostatistic experts but also to
bench researchers with a limited knowledge of bioinfor-
matics. The database allows multiple levels of access.
Firstly, access to the data is provided through a custom-
ized version of MartView, a BioMart web-based query
interface based on Perl API [28]. The interface is navigated
using the left panel with user selections taking place in the
right panel. A summary of user choices is also displayed in
the left panel. A simple query involves choosing attributes
(or using the default ones) and optionally filters if one
wants to restrict the query (Figure 1). Secondly, the Pan-
creatic Expression database is available from the BioMart
central server (Figure 2A) where it is exposed to third party
software such as the Bioconductor [29] package biomaRt
[30] therefore allowing its easy interrogation within the
open source R statistical environment [31] and its integra-
tion into any expression profiling experiment (Figure 2B).
In addition, the database is exposed to the Taverna work-
flow system [32] (Figure 2C) and to the Galaxy framework
(Figure 2D) [33]. The data can be also accessed program-
matically through web services (Figure 3) [34]. A query
constructed in the web-based query interface can be easily
converted into an xml or perl template for future bioinfor-
matics expansion and use. Finally, the Pancreatic Expres-
sion database is a DAS server providing a Pancreatic
Expression DAS annotation available at the Ensembl
GeneView (Figure 4) [5].
Examples of use
Navigation between all data types is simple and user-
friendly; a variety of possible query combinations allow
researchers quickly to determine the most de-regulated
genes and proteins across all platforms.
Using the Pancreatic Expression database, it is possible to
search and retrieve genes/proteins expressed only in pan-
creatic cancer and not in chronic pancreatitis and then ask
which of these are present in urine and/or plasma. Such a
query would be a first step for the discovery of non-inva-
sive pancreatic cancer biomarkers from body fluids (Fig-
ure 5).
Researchers interested in the genes involved in the pro-
gression of pancreatic cancer can select the corresponding
information among the differential expression datasets
for the various tumour stages and retrieve the genes found
to be de-regulated in the progression of pancreatic cancer
(Figure 6). In the same way, one can search for genes spe-
cific to certain types of pancreatic cancer (Figure 1B).
Our database also allows cross-platform meta-analysis.
Scientists can investigate pancreatic expression profiling
performed across a wide range of different platforms
(such as cDNA arrays or oligo arrays) to detect the most
consistent sets of de-regulated genes (Figure 7). Impor-
tantly, scientists can also retrieve the sets of overlapping
genes between their own results obtained by their partic-
ular platform (Proteomics, Affymetrix, Illumina etc.) and
annotation method (UniProt, RefSeq, HGNC Hugo etc.)
and those reported in the studies stored in the Pancreatic
Expression database (Figure 8).
As they are available through the BiomaRt package [30],
annotations can be added to any disease expression pro-
filing experiment, which will allow detection of genes de-
regulated in both pancreatic cancer and any other disease
(Figure 2B). One can also obtain the gene ontology classi-
fication of the retrieved datasets or mine the genes of
interest for a specific ontology term (Figure 9). Investiga-
tions using association studies can be designed using the
Pancreatic Expression database by selecting a specific cat-
egory of functional consequences (coding non-synony-
mous, 3' UTR, 5' UTR, splice site etc.) for SNPs associated
with genes involved in pancreatic cancer (Figure 10).
Expression data from a specific anatomical site can also be
retrieved (Figure 11). Researchers can obtain immunohis-
tochemistry data, where available, by selecting the anti-
bodies filter (Figure 12). Scientists interested in promoter
analysis can easily combine the gene search with theBMC Genomics 2007, 8:439 http://www.biomedcentral.com/1471-2164/8/439
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human genome upstream sequences and therefore collect
the promoter sequences in a fast and simple way allowing
further analysis of transcription factor-binding sites (Fig-
ure 1A).
Conclusion
Our integration model brings together relevant pancreatic
cancer datasets and annotations from public sources and
enables scientists to perform a wide variety of complex
The Pancreatic Expression database web-based query interface Figure 1
The Pancreatic Expression database web-based query interface. In this first example our goal was to identify differentially regu-
lated genes in pancreatic cancer found in microdissected samples only and/or to extract the upstream sequence data for these genes. This 
query starts by choosing the "Pancreatic Expression Database" from the "Choose Database" drop-down selection in the right panel. Users 
will be automatically directed to the "Pancreas Expression (Build 36)" dataset with the left panel displaying the "Filters" and "Attributes" nodes 
with their default settings. The next step involves choosing the appropriate attributes and filters to restrict the query. Clicking on the "Fil-
ters" or "Attributes" nodes on the left will display the related page where "Filters" or "Attributes" are arranged into sections, which can be 
expanded/collapsed using the "+/-" box. To choose an attribute or a filter, users can simply click on the checkbox next to its description. 
A summary of the selected filters and attributes is automatically displayed in the left panel. Clicking on the "Count" button in the tool bar 
at any time when constructing the query will return the number of genes satisfying the pre-selected criteria. One can select the option to 
download the results to a file at the top of the result page and export them using the "GO" button. Again, there are options to change the 
format ("HTML", "CSV" for comma separated values, "TSV" for tab separated values, "XLS" for Excel, "ADF" for array description format) 
and whether to make the results unique. One can select a compressed file output and the query will run in the background to be down-
loaded later. One needs to provide an email address to receive an URL in a notification email that allows the query results to be down-
loaded. 1. Filter: in this example, the query was restricted by selecting the "Filters" node on the left and choosing the filter options on the 
right. Next, the filter section "GENES DIFFERENTIALLY EXPRESSED IN:" was expanded in order to select the "Pancreatic adenocarcinoma 
(PDAC) vs normal pancreas ND (microdissected normal ductal cells)" and limited the output to the "Pancreatic adenocarcinoma (PDAC) vs normal 
pancreas ND (microdissected normal ductal cells)" from the "Limit Output to" drop down menu. This is to avoid retrieving all the information 
about the genes satisfying the search criteria. 2. Attributes: these are arranged into five pages for "General Gene Features", "Genomic Struc-
tures", "GENE SNP Associations", "Homologs" and "Sequences". In order to select the output content, the "Attributes" node on the left needs 
to be clicked on and the attribute page on the right needs to be chosen. A. from the "Sequences" attribute page, the section "SEQUENCES" 
was expanded and "5' UTR" selected by typing in "1000" basepair as an "Upstream flank". B. from the "General Gene Features" attribute 
page, one can expand the attribute section "PANCREATIC EXPRESSION" where the "Gene Symbol", "Ensembl Gene ID", "Differential Expres-
sion Analysis" and "Direction of Regulation" default options are displayed. 3. Results: clicking on the "Count" button displays 1082 genes sat-
isfying the search criteria. Clicking on the "Results" button on the toolbar retrieves the final query results. By default, this shows the first 
10 results in fasta format (A) and in hyper-linked HTML format (B) but the number and format can be altered using the drop-downs 
above this preview, as described above. Checking the "Unique results only" in (B) displays the unique rows only from the result table.BMC Genomics 2007, 8:439 http://www.biomedcentral.com/1471-2164/8/439
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queries on various types of data. The design of the data-
base allows easy integration of additional modules and
annotations from new public databases.
The Pancreatic Expression database constitutes a unique
and valuable resource for the wider cancer research com-
munity, and is in rapid and constant development. We
aim to continuously import new data sources and update
the database on a regular basis, and invite scientists world-
wide to deposit and share their data.
Although initially constructed using pancreatic cancer
expression datasets, we have designed and implemented a
generic system that can be easily modified and applied to
any other type of cancer. The system is available for col-
laboration with all interested research groups either by
extending it to include other cancer data or by sharing our
model should they want to adopt it for their data.
Availability and requirements
Project name: Pancreatic Expression database
Project home page: http://www.pancreasexpression.org
Operating system(s): Platform independent; Standard
WWW browser (Safari, Firefox)
Access through third party software Figure 2
Access through third party software. The Pancreatic Expression database allows multiple levels of access. A – Access from the 
BioMart central server. B – Access within the open source R statistical environment through the biomaRt bioconductor package. C – 
Access from Taverna workflow system. D – Access with Galaxy.BMC Genomics 2007, 8:439 http://www.biomedcentral.com/1471-2164/8/439
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Programming language: Perl, SQL, BioMart data manage-
ment system
Licence: The database is freely available to academic and
non-academic users. However, should you find the Pan-
creatic Expression database useful to your work, please
cite this paper.
Authors' contributions
CC designed and implemented the web site and database,
annotated and integrated the data, contributed to the data
collection and wrote the manuscript. SAH defined the
pancreatic cancer modules, collected pancreatic data,
tested the database, contributed to the revision of the
manuscript and continuous discussion. HJW, SB, DH and
TPR were involved in the pancreatic data collection. TCJ
contributed to the definition of the pancreatic cancer
modules and pancreatic data collection. TCJ and NRL pro-
vided valuable guidance and expertise on pancreatic can-
cer, contributed to the critical revision of the manuscript
and continuous discussion. All authors read the final
manuscript.
Access provided programmatically through web services Figure 3
Access provided programmatically through web services. In this example we show how to submit a query using web services. 
One can generate an XML or Perl script by building up a query using the web-based user interface (as described in Figure 1) and hitting 
the XML or Perl button on the right side of the toolbar. One can save the query as query.xml or query.pl and then use it to query the 
database.BMC Genomics 2007, 8:439 http://www.biomedcentral.com/1471-2164/8/439
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The Pancreatic Expression DAS annotation available at the Ensembl GeneView Figure 4
The Pancreatic Expression DAS annotation available at the Ensembl GeneView. The figure shows the Ensembl GeneView 
report for the ENSG00000038427 gene. The Pancreatic Expression database query results return Ensembl Gene ID by default with a 
hyper-link to the Ensembl GeneView website. In the Gene DAS Report section, which can be expanded/collapsed using the "+/-" box, a 
list of all the DAS sources including the Pancreatic Expression database is provided. To display the Pancreatic Expression database anno-
tations, one can simply click on the checkbox next to the Pancreatic Expression and press the Update button at the end of the DAS 
sources.BMC Genomics 2007, 8:439 http://www.biomedcentral.com/1471-2164/8/439
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Biomarker discovery Figure 5
Biomarker discovery. The goal of this example was to retrieve genes expressed only in pancreatic cancer, not expressed in chronic 
pancreatitis and present in plasma. 1. Filter: the query is restricted by clicking on the "Filters" node on the left, expanding the filter section 
"GENES DIFFERENTIALLY EXPRESSED IN:" and selecting for genes differentially expressed in "Pancreatic adenocarcinoma (PDAC) vs normal 
pancreas NP (bulk tissue)" as well as "Pancreatic adenocarcinoma (PDAC) vs chronic pancreatitis (bulk tissue)" and expanding the filter section 
"GENES EXPRESSED IN:" and selecting for genes expressed in "Plasma". 2. Attributes: selected by clicking on the "Attributes" node on the 
left, choosing the "General Gene Features" attribute page, expanding the attribute section "PANCREATIC EXPRESSION" to remove "Gene 
Symbol", "Differential Expression Analysis" and "Direction of Regulation" default options, expanding the attribute section "GENE" and selecting 
"Description" under "Ensembl Attributes". 3. Results: Clicking the "Count" button in the tool bar returns 37 genes satisfying the filters crite-
ria. Clicking the "Results" button on the toolbar will retrieve a result table. Checking the "Unique results only" will display only the unique 
rows of the result table.BMC Genomics 2007, 8:439 http://www.biomedcentral.com/1471-2164/8/439
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Genes involved in the progression of pancreatic cancer Figure 6
Genes involved in the progression of pancreatic cancer. The goal of this example was to query the differentially expressed infor-
mation for pancreatic tumour stages (pancreatic intraepithelial neoplasias and pancreatic adenocarcinoma) and to retrieve the genes 
found to be de-regulated in the progression of pancreatic cancer. 1. Filter: one can choose "Pancreatic intraepithelial neoplasias (PanIN-2) vs 
normal pancreas ND (microdissected normal ductal cells)", "Pancreatic intraepithelial neoplasias (PanIN-3) vs normal pancreas ND (microdissected 
normal ductal cells)" and "Pancreatic adenocarcinoma (PDAC) vs normal pancreas NP (bulk tissue)" from the filter section "GENES DIFFEREN-
TIALLY EXPRESSED IN:". 2. Attributes: one can choose the "General Gene Features" attribute page, expand the attribute section "PANCRE-
ATIC EXPRESSION" to remove "Gene Symbol", "Differential Expression Analysis" and "Direction of Regulation" default options, expand the 
attribute section "GENE" and select "Description" under "Ensembl Attributes". 3. Results: Clicking the "Count" button in the tool bar returns 
10 genes involved in the progression of pancreatic cancer.BMC Genomics 2007, 8:439 http://www.biomedcentral.com/1471-2164/8/439
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Cross-platform analysis of pancreatic cancer data in the database Figure 7
Cross-platform analysis of pancreatic cancer data in the database. The goal of this example was to investigate pancreatic 
expression profiling data obtained using cDNA and oligo arrays and to retrieve the common set of de-regulated genes. One can proceed 
as follows: 1. Filters: restrict the query by clicking on the "Filters" node on the left. Choose the cancer subtype, for example by expanding 
the filter section "GENES DIFFERENTIALLY EXPRESSED IN:" and selecting for genes differentially expressed in "Pancreatic adenocarcinoma 
(PDAC) vs normal pancreas NP (bulk tissue)", expanding the filter section "PLATFORM TECHNOLOGY:" and selecting both "Oligo array" and 
"cDNA array". 2. Attributes: select attributes by clicking on the "Attributes" node on the left, choosing the "General Gene Features" attribute 
page, expanding the attribute section "PANCREATIC EXPRESSION" to remove "Gene Symbol", "Differential Expression Analysis" and "Direction 
of Regulation" default options, expanding the attribute section "GENE" and selecting "Description" under "Ensembl Attributes". 3. Results: hit-
ting the "Count" button retrieves 141 de-regulated genes in cancer when using both oligo and cDNA platforms. One can proceed to sav-
ing the whole result set by choosing the appropriate action(s) at the top of the page, for example in an Excel format, and clicking the "Go" 
button to export the results.BMC Genomics 2007, 8:439 http://www.biomedcentral.com/1471-2164/8/439
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Meta-analysis of pancreatic cancer data Figure 8
Meta-analysis of pancreatic cancer data. In this example, our goal was to retrieve the sets of overlapping genes between user's data 
obtained by a proteomics platform with IPI identifiers and those reported in the studies stored in the Pancreatic Expression database. 1. 
Filter: one can restrict the query by clicking on the "Filters" node on the left and expanding the filter section "GENE RELATED ACCES-
SIONS:" using the "+" box. Next one can choose the "ID" list limit simply by clicking on the left checkbox and selecting the identifiers for 
the experimental results from the right drop-down menu. In this example, the "IPI ID(s)" is used but one can choose any other identifiers 
such as Uniprot, Affymetrix or Illumina etc. One can copy and paste the list of identifiers in the box or browse to read directly from a file. 
2. Attributes: one can click on the "Attributes" node on the left and start choosing attributes from the "General Gene Features" page. One 
can expand the "PANCREATIC EXPRESSION:" section or other sections and check other attributes to add to the results. 3. Results: for sav-
ing the whole result set, one can choose the appropriate action(s) at the top of the page, select the format, for example Excel, and click 
the "Go" button to export the results.BMC Genomics 2007, 8:439 http://www.biomedcentral.com/1471-2164/8/439
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Ontology for pancreatic cancer genes Figure 9
Ontology for pancreatic cancer genes. The goal of this example was to obtain the gene ontology classification of the genes differen-
tially expressed in intraductal papillary mucinous neoplasms (IPMN) and/or mine the retrieved genes for cell proliferation process using 
the ontology term GO:0008283. 1. Filter: one can restrict the query by clicking on the "Filters" node on the left and selecting filters on 
the right. A. restriction to a cancer subtype comparison, for example by expanding the filter section "GENES DIFFERENTIALLY EXPRESSED 
IN:" and selecting for genes differentially expressed in "Intraductal papillary mucinous neoplasms (IPMN) vs cell line" B. restriction to a cancer 
subtype comparison and cell proliferation biological process "GO:0008283" by expanding the filter section "GENES DIFFERENTIALLY 
EXPRESSED IN:" and selecting for genes differentially expressed in "Intraductal papillary mucinous neoplasms (IPMN) vs cell line", expanding 
the filter section "GENE ONTOLOGY:", selecting "Biological process" and typing in "GO:0008283". 2. Attributes: one can select attributes by 
clicking on the "Attributes" node on the left, choosing the "General Gene Features" attribute page, expanding the attribute section "PANCRE-
ATIC EXPRESSION" to remove "Differential Expression Analysis" and "Direction of Regulation" default options, expanding the attribute section 
"GENE" and selecting "GO ID" under the "GO Attributes". 3. Results: one can preview the results by clicking the "Results" button on the 
toolbar. By default this shows the first 10 results for A and B in hyper-linked HTML. The number and format can be altered using the 
drop downs above this preview.BMC Genomics 2007, 8:439 http://www.biomedcentral.com/1471-2164/8/439
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Design of pancreatic cancer association studies Figure 10
Design of pancreatic cancer association studies. The goal of this example was to target SNPs for pancreatic cancer association 
studies by selecting for coding non-synonymous, validated SNPs with frequency data associated with genes involved in pancreatic cancer. 
1. Filter: one can restrict the query by clicking on the "Filters" node on the left and selecting "Up-regulated" from the filter section "PAN-
CREATIC DIFFERENTIAL EXPRESSION INFORMATION:", "Fine needle aspirate vs normal pancreas NP (bulk tissue)" from the filter section 
"GENES DIFFERENTIALLY EXPRESSED IN:" and "Chromosome 2" from the filter section "GENOMIC REGION". For SNP filters, one can 
expand the filter section "GENE ASSOCIATED WITH SNP:", select "SNP type" as "coding" from its drop down menu, "Synonymous status" as 
"Non-synonymous SNPs" from its drop down menu as well as "Associated with validated SNPs" and "Associated with SNPs with frequency data". 
2. Attributes: one can click on the "Attributes" node on the left and start choosing attributes on the right from the "Gene SNP associations" 
attribute page. In this example, one can expand the attribute section "PANCREATIC EXPRESSION" to remove "Differential Expression Analy-
sis" and "Direction of Regulation" default options, expand the attribute section "GENE" to select "Transcript ID" under the "Ensembl 
Attributes", "Synonymous SNP count" and "Non-synonymous SNP count" under "Gene SNP Attributes", expand the "GENE ASSOCIATED 
SNPS:" section to select the "Reference ID", "Allele" and "Validation status" under the "SNP Attributes", "Transcript location (bp)", "SNP Chromo-
some Strand", "Peptide location (aa)" and "Chromosome Location (bp)" under the "SNP Location Attributes:", and finally, "Location in Gene (coding 
etc)", "Peptide Shift" as well a "Synonymous Status" under the "Gene Location and Effect". 3. Results: one can preview the results by clicking 
the "Results" button on the toolbar. For particularly intensive queries, which is true in this example, one can use the web file options by 
entering an email address. An email will then be sent to the given address when the results are ready and one can click on the link in the 
email to download the results. In this example, results are viewed and filtered with Excel.BMC Genomics 2007, 8:439 http://www.biomedcentral.com/1471-2164/8/439
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Pancreatic cancer gene expression Figure 11
Pancreatic cancer gene expression. In this example, our goal was to retrieve additional expression data from a specific anatomical 
site for genes differentially regulated in neuroendocrine tumours (PEN). 1. Filter: one can restrict the query by clicking on the "Filters" 
node on the left, expanding the filter section "GENES DIFFERENTIALLY EXPRESSED IN:" to restricted the query for genes differentially 
expressed in "Neuroendocrine tumours (PEN) vs islet cell". Next, one can expand the filter section "EXPRESSION PATTERNS:" and restrict the 
query further to genes having expression profiles in pancreas and tumour by selecting. "eGenetics/SANBI EST anatomical system data" for 
"pancreas" (eGenetics/SANBI EST anatomical system data -> alimentary -> pancreas) and the "eGenetics/SANBI EST pathology data" for "tumour" 
(eGenetics/SANBI EST pathology data -> neoplasia -> tumour). 2. Attributes: one can click on the "Attributes" node on the left and start choos-
ing attributes on the right. In this example, one can choose the "General Gene Features" attribute page, expand the attribute section "PAN-
CREATIC EXPRESSION" to remove "Differential Expression Analysis" and "Direction of Regulation" options selected by default, expand the 
attribute section "EXPRESSION:" and select the "eGenetics/SANBI" under the "Source of Expression Data". 3. Results: one can preview the 
results by clicking the Results button on the toolbar.BMC Genomics 2007, 8:439 http://www.biomedcentral.com/1471-2164/8/439
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Disclaimer: Information in the Pancreatic Expression database is curated 
from highly relevant published pancreatic cancer papers. However, the 
quality and accuracy of the published data are solely the responsibility of the 
authors. The Pancreatic Expression database is a mining tool to the litera-
ture rather than a substitute for the experiments. We highly recommend 
researchers to trace the origin of the data to check if the data may comply 
with their quality standards. We also recommend researchers to apply 
independent technologies to confirm data retrieved through our mining 
tool prior to integrating them into the individual research efforts.
References
1. Schneider G, Siveke JT, Eckel F, Schmid RM: Pancreatic cancer:
basic and clinical aspects.  Gastroenterology 2005,
128(6):1606-1625.
2. Pancreatic Expression database   [http://www.pancreasexpres
sion.org]
3. MySQL   [http://www.mysql.com]
4. BioMart   [http://www.biomart.org]
5. Ensembl   [http://www.ensembl.org]
Immunohistochemistry data Figure 12
Immunohistochemistry data. In this example, the goal was to show how to obtain immunohistochemistry data for the E-cadherin 
gene. 1. Filter: one can restrict the query by clicking on the "Filters" node on the left, expanding the filter section "GENE RELATED ACCES-
SIONS:" using the "+" box, choosing the "ID" list limit simply by clicking on the left checkbox and selecting the "HGNC Symbol(s)" and typ-
ing in the E-cadherin gene symbol "CDH1". 2. Attributes: one can click on the "Attributes" node on the left and start choosing attributes 
from the "General Gene Features" page. In this example, one can expand the "PANCREATIC EXPRESSION:" section, check "Ensembl Gene ID", 
"Specimen or Cell type", "Platform" under "Expression Attributes" and "Study" under "Origin of data". Once can also expand the "GENE:" section 
to check "HGNC Symbol" under the "External References (max 3)" and "ANTIBODIES:" to check "Antibody ID". 3. Results: one can click the 
"Results" button to view the results. The antibody ID for "CDH1" is displayed with a hyper-link to the Human Protein Atlas where immu-
nohistochemistry data for normal and cancer tissues, as well as for cell lines, can be displayed.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Genomics 2007, 8:439 http://www.biomedcentral.com/1471-2164/8/439
Page 16 of 16
(page number not for citation purposes)
6. Ensembl microarray probeset mapping   [http://
www.ensembl.org/info/about/docs/
microarray_probe_set_mapping.html]
7. Human Protein Atlas   [http://www.proteinatlas.org]
8. Van Heek NT, Maitra A, Koopmann J, Fedarko N, Jain A, Rahman A,
Iacobuzio-Donahue CA, Adsay V, Ashfaq R, Yeo CJ, Cameron JL,
Offerhaus JA, Hruban RH, Berg KD, Goggins M: Gene expression
profiling identifies markers of ampullary adenocarcinoma.
Cancer Biol Ther 2004, 3(7):651-656.
9. Adachi J, Kumar C, Zhang Y, Olsen JV, Mann M: The human uri-
nary proteome contains more than 1500 proteins, including
a large proportion of membrane proteins.  Genome Biol 2006,
7(9):R80.
10. Anderson NL, Polanski M, Pieper R, Gatlin T, Tirumalai RS, Conrads
TP, Veenstra TD, Adkins JN, Pounds JG, Fagan R, Lobley A: The
human plasma proteome: a nonredundant list developed by
combination of four separate sources.  Mol Cell Proteomics 2004,
3(4):311-326.
11. Buchholz M, Braun M, Heidenblut A, Kestler HA, Kloppel G,
Schmiegel W, Hahn SA, Luttges J, Gress TM: Transcriptome anal-
ysis of microdissected pancreatic intraepithelial neoplastic
lesions.  Oncogene 2005, 24(44):6626-6636.
12. Crnogorac-Jurcevic T, Efthimiou E, Capelli P, Blaveri E, Baron A, Ter-
ris B, Jones M, Tyson K, Bassi C, Scarpa A, Lemoine NR: Gene
expression profiles of pancreatic cancer and stromal desmo-
plasia.  Oncogene 2001, 20(50):7437-7446.
13. Crnogorac-Jurcevic T, Efthimiou E, Nielsen T, Loader J, Terris B,
Stamp G, Baron A, Scarpa A, Lemoine NR: Expression profiling of
microdissected pancreatic adenocarcinomas.  Oncogene 2002,
21(29):4587-4594.
14. Crnogorac-Jurcevic T, Gangeswaran R, Bhakta V, Capurso G, Latti-
more S, Akada M, Sunamura M, Prime W, Campbell F, Brentnall TA,
Costello E, Neoptolemos J, Lemoine NR: Proteomic analysis of
chronic pancreatitis and pancreatic adenocarcinoma.  Gastro-
enterology 2005, 129(5):1454-1463.
15. Crnogorac-Jurcevic T, Missiaglia E, Blaveri E, Gangeswaran R, Jones M,
Terris B, Costello E, Neoptolemos JP, Lemoine NR: Molecular
alterations in pancreatic carcinoma: expression profiling
shows that dysregulated expression of S100 genes is highly
prevalent.  J Pathol 2003, 201(1):63-74.
16. Friess H, Ding J, Kleeff J, Fenkell L, Rosinski JA, Guweidhi A, Reidhaar-
Olson JF, Korc M, Hammer J, Buchler MW: Microarray-based
identification of differentially expressed growth- and metas-
tasis-associated genes in pancreatic cancer.  Cell Mol Life Sci
2003, 60(6):1180-1199.
17. Grutzmann R, Pilarsky C, Ammerpohl O, Luttges J, Bohme A, Sipos
B, Foerder M, Alldinger I, Jahnke B, Schackert HK, Kalthoff H, Kremer
B, Kloppel G, Saeger HD: Gene expression profiling of microdis-
sected pancreatic ductal carcinomas using high-density DNA
microarrays.  Neoplasia 2004, 6(5):611-622.
18. Hu L, Evers S, Lu ZH, Shen Y, Chen J: Two-dimensional protein
database of human pancreas.  Electrophoresis 2004,
25(3):512-518.
19. Iacobuzio-Donahue CA, Maitra A, Shen-Ong GL, van Heek T, Ashfaq
R, Meyer R, Walter K, Berg K, Hollingsworth MA, Cameron JL, Yeo
CJ, Kern SE, Goggins M, Hruban RH: Discovery of novel tumor
markers of pancreatic cancer using global gene expression
technology.  Am J Pathol 2002, 160(4):1239-1249.
20. Logsdon CD, Simeone DM, Binkley C, Arumugam T, Greenson JK,
Giordano TJ, Misek DE, Kuick R, Hanash S: Molecular profiling of
pancreatic adenocarcinoma and chronic pancreatitis identi-
fies multiple genes differentially regulated in pancreatic can-
cer.  Cancer Res 2003, 63(10):2649-2657.
21. Lu Z, Hu L, Evers S, Chen J, Shen Y: Differential expression pro-
filing of human pancreatic adenocarcinoma and healthy pan-
creatic tissue.  Proteomics 2004, 4(12):3975-3988.
22. Maitra A, Hansel DE, Argani P, Ashfaq R, Rahman A, Naji A, Deng S,
Geradts J, Hawthorne L, House MG, Yeo CJ: Global expression
analysis of well-differentiated pancreatic endocrine neo-
plasms using oligonucleotide microarrays.  Clin Cancer Res
2003, 9(16 Pt 1):5988-5995.
23. Nakamura T, Furukawa Y, Nakagawa H, Tsunoda T, Ohigashi H,
Murata K, Ishikawa O, Ohgaki K, Kashimura N, Miyamoto M, Hirano
S, Kondo S, Katoh H, Nakamura Y, Katagiri T: Genome-wide
cDNA microarray analysis of gene expression profiles in pan-
creatic cancers using populations of tumor cells and normal
ductal epithelial cells selected for purity by laser microdis-
section.  Oncogene 2004, 23(13):2385-2400.
24. Segara D, Biankin AV, Kench JG, Langusch CC, Dawson AC, Skalicky
DA, Gotley DC, Coleman MJ, Sutherland RL, Henshall SM: Expres-
sion of HOXB2, a retinoic acid signaling target in pancreatic
cancer and pancreatic intraepithelial neoplasia.  Clin Cancer Res
2005, 11(9):3587-3596.
25. Shen J, Person MD, Zhu J, Abbruzzese JL, Li D: Protein expression
profiles in pancreatic adenocarcinoma compared with nor-
mal pancreatic tissue and tissue affected by pancreatitis as
detected by two-dimensional gel electrophoresis and mass
spectrometry.  Cancer Res 2004, 64(24):9018-9026.
26. Tan ZJ, Hu XG, Cao GS, Tang Y: Analysis of gene expression pro-
file of pancreatic carcinoma using cDNA microarray.  World J
Gastroenterol 2003, 9(4):818-823.
27. Terris B, Blaveri E, Crnogorac-Jurcevic T, Jones M, Missiaglia E,
Ruszniewski P, Sauvanet A, Lemoine NR: Characterization of
gene expression profiles in intraductal papillary-mucinous
tumors of the pancreas.  Am J Pathol 2002, 160(5):1745-1754.
28. Pancreatic Expression database web-based query interface
[http://www.pancreasexpression.org/biomart/martview]
29. Bioconductor   [http://www.bioconductor.org]
30. Durinck S, Moreau Y, Kasprzyk A, Davis S, De Moor B, Brazma A,
Huber W: BioMart and Bioconductor: a powerful link
between biological databases and microarray data analysis.
Bioinformatics 2005, 21(16):3439-3440.
31. R project   [http://www.r-project.org]
32. Hull D, Wolstencroft K, Stevens R, Goble C, Pocock MR, Li P, Oinn
T: Taverna: a tool for building and running workflows of serv-
ices.  Nucleic Acids Res 2006, 34(Web Server issue):W729-32.
33. Galaxy   [http://main.g2.bx.psu.edu]
34. Pancreatic Expression database access through web services
[http://www.pancreasexpression.org/biomart/martservice]